Scientific Reports (Aug 2022)

A novel splice variant of Elp3/Kat9 regulates mitochondrial tRNA modification and function

  • Rachid Boutoual,
  • Hyunsun Jo,
  • Indra Heckenbach,
  • Ritesh Tiwari,
  • Herbert Kasler,
  • Chad A. Lerner,
  • Samah Shah,
  • Birgit Schilling,
  • Vincenzo Calvanese,
  • Matthew J. Rardin,
  • Morten Scheibye-Knudsen,
  • Eric Verdin

DOI
https://doi.org/10.1038/s41598-022-18114-x
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Post-translational modifications, such as lysine acetylation, regulate the activity of diverse proteins across many cellular compartments. Protein deacetylation in mitochondria is catalyzed by the enzymatic activity of the NAD+-dependent deacetylase sirtuin 3 (SIRT3), however it remains unclear whether corresponding mitochondrial acetyltransferases exist. We used a bioinformatics approach to search for mitochondrial proteins with an acetyltransferase catalytic domain, and identified a novel splice variant of ELP3 (mt-ELP3) of the elongator complex, which localizes to the mitochondrial matrix in mammalian cells. Unexpectedly, mt-ELP3 does not mediate mitochondrial protein acetylation but instead induces a post-transcriptional modification of mitochondrial-transfer RNAs (mt-tRNAs). Overexpression of mt-ELP3 leads to the protection of mt-tRNAs against the tRNA-specific RNase angiogenin, increases mitochondrial translation, and furthermore increases expression of OXPHOS complexes. This study thus identifies mt-ELP3 as a non-canonical mt-tRNA modifying enzyme.